Financial Performance - Auna's consolidated revenue for Q1 2025 was S/ 1,042 million, a decrease of 3% year-over-year, but an increase of 4% on a foreign exchange neutral basis[19] - Adjusted EBITDA for Q1 2025 was S/ 222 million, down 8% year-over-year, but up 1% on a foreign exchange neutral basis, with a margin of 214%[19] - Adjusted Net Income increased 15x year-over-year, marking the fifth consecutive quarter of positive Adjusted Net Income[48] - The leverage ratio remained flat at 36x[16] Segment Performance - Healthcare Services in Mexico saw a revenue decrease of 21% to S/ 243 million, impacted by new doctor/supplier standards[25] - Healthcare Services in Peru & Oncosalud Peru experienced a revenue increase of 10% to S/ 460 million[28] - Healthcare Services in Colombia reported a revenue decrease of 3% to S/ 339 million[34] Cash Flow and Debt - End-of-period cash decreased 15% compared to Q4 2024[54] - The company successfully offered an additional $621 million in aggregate principal amount of the 10000% senior secured notes due 2029 in May 2025[57] - Consolidated debt was S/ 3,735 million, with more than half in direct local currency funding and the remaining US$ debt 94% hedged to PEN[57]
Auna S.A.(AUNA) - 2025 Q1 - Earnings Call Presentation